Clinical Trials Directory

Trials / Completed

CompletedNCT03590886

Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response

A Clinical Study About Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To compare intestinal flora diversity in different PBC patients with UDCA responses, and further study the differences of bile acid metabolism and short chain fatty acid metabolism in feces and serum of two groups of PBC patients.

Detailed description

The PBC patients have been enrolled in the study for UDCA treatment more than 1 year, who is divided into the UDCA total response Group and the other poor response group according to Paris-I/II standard .The feces of two groups of patients were collected and the differences of microbial polymorphism of fecal microorganism in two groups were observed. The metabolic differences of bile acids and short chain fatty acids in serum and feces of two groups of PBC patients were studied by means of metabolic proteomics.

Conditions

Interventions

TypeNameDescription
OTHERtotal response Groupbiochemical response for UDCA treatment more than 1 year according to Paris-I/II standard

Timeline

Start date
2018-08-22
Primary completion
2018-12-31
Completion
2019-02-28
First posted
2018-07-18
Last updated
2019-12-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03590886. Inclusion in this directory is not an endorsement.